The Future of Infectious Disease Screening

GIANT delivers rapid antimicrobial susceptibility testing (AST) in 2 hours - enabling faster, more targeted treatment decisions when every hour matters.

Learn About GIANT

Global Problem, GIANT Opportunity

Sepsis is a deadly condition caused by bloodstream infections, and delays in effective therapy cost lives.

GIANT addresses this urgent challenge with a strong infectious disease testing opportunity and meaningful hospital cost-reduction impact.

1
Death every 3 seconds

From sepsis globally.

$62B
Annual hospital cost

U.S. annual cost associated with sepsis.

Why GIANT Is the Best Solution

GIANT combines speed, accuracy, usability, and cost efficiency to support earlier targeted therapy decisions.

Ultra Fast

2-hour time to result to support faster therapy decisions.

Small Sample Volume

200x reduction in sample volume using high-precision microfluidics.

Profitable Unit Economics

Cost-effective, with strong economics versus many alternatives.

One-Step Loading

Simple workflow with easy analysis using a commercial plate reader or mobile device.

Get in Touch